uOBMRI’s Centre for Neuromuscular Disease and Université Claude Bernard partners with nearly $1M research investments
Posted on Thursday, August 17, 2017
Author: Faculty of Medicine, uOttawa
uOttawa Faculty of Medicine and uOttawa Brain and Mind Research Institute’s Centre for Neuromuscular Disease (CNMD) have now officially established a strategic partnership with the Institute NeuroMyoGene (INMG) at Université Claude Bernard in Lyon, France, which will provide almost $1,000,000 CAD over 5 years for collaborative research projects between the two institutes.
The CNMD/INMG partnership will enhance the research productivity and visibility of both institutes, and provide an innovative, international environment to train the next generation of NMD basic and clinical researchers.
Neuromuscular disease (NMD) represents a broad group of more than 150 genetic and acquired disorders, many of which cause progressive muscle wasting and premature death.